Non-ischemic cardiomyopathy (NICM) is one of the most important entities for arrhythmias
and sudden cardiac death (SCD). Previous studies suggest a lower benefit of implantable …

Risk stratification for ventricular arrhythmias (VAs) and sudden cardiac death (SCD) in
nonischemic cardiomyopathy (NICM) is a key unresolved issue. Poor risk stratification is …

Sudden cardiac death (SCD) is a major cause of mortality in patients with nonischemic
cardiomyopathy (NICM). Identifying patients who are at highest risk for SCD is an ongoing …

Non-ischemic dilated cardiomyopathy (DCM) is a disease characterized by left ventricular
dilation and systolic dysfunction. Patients with DCM are at higher risk for ventricular …

Sudden cardiac death and arrhythmia-related events in patients with non-ischaemic dilated
cardiomyopathy (NICM) have been significantly reduced over the last couple of decades as …

Introduction: Risk stratification for sudden cardiac death in non-ischemic dilated
cardiomyopathy (NIDCM) remains a clinical challenge. Areas covered: Currently, left …

Aims The aim of this registry was to evaluate the additional prognostic value of a composite
cardiac magnetic resonance (CMR)-based risk score over standard-of-care (SOC) …

The prevention of sudden cardiac death (SCD) in cardiomyopathies (CM) remains a
challenge. The current guidelines still favor the implantation of devices for the primary …

Nonischemic cardiomyopathy (NICM) is common and patients are at significant risk for early
mortality secondary to ventricular arrhythmias. Current guidelines recommend implantable …

Background For patients with nonischemic cardiomyopathy (NICM), current guidelines
recommend implantable cardioverter defibrillators (ICD) when left ventricular ejection …